Frank, if you don't listen to your own mother, so I wouldn't expect you to listen to me...
you always come up with these phantom trades that after the facts.. not everyone on this MB can be as slick as you.. so you can believe whatever you want..
BTW, I made good money selling call options for the past 2 weeks and have been waiting to get back in CLDX after sold my shares at $31.. technically I should have waited until it drops below $21 to buy back in, but the last few days seemed to hold at the lower boundary of the uptrend channel .. so here I am, owning CLDX again until price reaches to supply zone.. I invested for profit, not an unpaid pumper like these "super traders" on this board.. (most of them bought CLDX between $2-$5 a long time ago, and now they're in the auto-pilot mode...) GL...
by analyzing weekly OI, I think Friday could be moving sideway to close between strike prices. around 37.50.. if YHOO could test $39 on Monday, then it could reached $41 by the end of next week.. GL
good technical trade at this level ..Set stop limit at 22.50 just in case sum ting wong..... GL
This is stupid to watch the way YHOO stock is being manipuated, MMs drive down on the day with good news, and stock surged on no news days..
WS is an corrupted institution..
biotech company is one bad news away from 80% drop.. CLDX has its share of dropping more than 35% for the past 2 weeks after the suspension of the 1135 pilot trial.. In 2000, CLDX stock was $225, and now it is $25.. the reason I brought this up because GERN used to trade around $75 in 2000's too and now it worths less than $2.
The problem with Biotech's trial results is that many unexpected leaks, backdoor publications that general public don't get the information until it is too late.. stock price normally based on speculations or the potential. Not base on the economic and commercial values.
Biotech stocks just like owning a dead fish, if you keep too long, you may end up eating the smelly fish... set a tight stop limit to minimize your loss and set trailing stop when you're ahead.. sorry about your loss on GERN...
First, it's your money to invest, I don't need to convince you either way.. besides, people like you can't be convinced because you treat stock like region.. faith and emotion above logic..
~ institutions don't invest their own money.. they use money from MFs, 401K, IRA, Pension Plans and others to take higher risk than their own money.. why do you think big institutions like BAC, JMP lost a lot of money but their employees get huge bonuses ? 180M is small potato to compare with $10bil that they managed.
~ CLDX is not the only company seeking leukemia curing drugs, every biotech companies seem to claim some sort of new methods of treating these rare deseases and their success is depending on the pipeline of drugs that focusing on cancer from A-Z . Many biotech companies normally passed P1 and P2 trials but failed miserably at the later trials simply because FDA required larger patients base then cherry picking patients at the early stages. A few cancer survivors for a long period of time may or may not meet the hypothesis statistical significant of a trial.
~ Chinese medicines and acupunture mehods also cured many diseases and cancers (including breast cancers). Many patients gave up hope in western medicine.. but no one should claim Chinese medicine is better or worst than western medicine.. because each type of approach can benefit for a few illnesses but not cure all..
~ physicians are human too, sometime they's so focusing on finding the cure so they may not see the tree from the forest in term of the limitations of the drugs.. just like you never think your children are ugly unless you get the second opinion from an independent source.
w/o FDA approval, these talking points become nothing and it has no commercial value.. CLDX should focus on the quality of drug, rather than a large quantity of drugs but none get approved by the FDA. GL
you're only up 5X and you're lecturing other people not to invest in biotech's.. what ifs someone is up 10X, would you listen to them ? I have learned that 99% of pumpers, I mean investors on the MB have bought CLDX when it was $1 to $5 range...
Somehow my calculator can't add up all the number of the outstanding shares.. 93% owned by institutions, 15% shares are currently shorted, insiders hold at least 10% ?, I was wondering what percentage are being held by posters on this MB because everyone of them seems to claim they own when it was in 1-5 range ??
if you invest $3mil in CLDX 30yrs ago, and you're not obsessed with daily fluctuations, how much do you have in your account today ? hmmm...
the way CLDX drop today signaled that big shorts/sellers are waiting to tank this stock.. they knocked it down every time it moves up.. if it holds 24ish level for the next few days, then it might have a chance to recover, if it drops below 200 day ma, I think this stock will be traded in teens until the trial results are announced.. GL
can you name one drug in the pipeline that CLDX can charge more than $500K per patient per year ? YES or NO ?
Ray, a couple weeks ago you and other pumpers were lazer focused on 1135, now you focus on something else.. how do we know a week from now which drugs you might focus on next.. and you expect us to think you know what you were talking about ???
how can you NOT focus on product that CLDX can charge $500K per patient/ yr.. how much can CLDX charge on other drugs per year per patient ?? can you share with us ? if you can tell me that oher drugs CLDX charge more than 1135, than I will never post again on this MB.
if these 5 recommendations have any credential, should CLDX stock up today ?
Unfortunately, stock price seems to suggest that wholesale investors are dumping their shares while retail investors are holding in hope that 12 months from now, CLDX stock will move higher from here...
Why should I believe any of these recs if stock price shows otherwise ?
what is stopping you from post all of it ? post it away...
relentless pumping from a gang of sheep...mis-interpreting the information for self-serving .. the information like "The economics of CDX-1135 is a critical factor, and for that reason I think they will focus an ultra-orphan diseases like DDD, where they can charge $500K/yr and get reimbursement (as ALXN does with Soliris)" ... this kind of baseless speculations needed to be stop...
I know who I am, so don't even try to put me in my place... because I'm already there.. you guys need to #$%$ so retail investors won't be victimized of the bioscams.. many posters on this MB already bought stock at the higher prices because of your pumping... Since CLDX announced the termination of 1135, now you guys trying to pump stock using other non-approved drugs.. what make you think that CLDX management won't terminate other trials as well ??? one SA article or one abstract of a report do not make CLDX a success unless the first FDA approval is secured.
this report highlights major breakthrough of 1135, investors should own CLDX.. read on....
I apologize for picking the wrong day for NWBO to go down above $10...it went down a day earlier.. I'm sure Frankie is very happy about that... hopefully he'll short CLDX next...LOLOLOLOLOLOL
Alibaba's new M&A should help value of YHOO, not de-valued.. please share your thoughts...
how can this article be an positive opinion wrt CLDX1135 ? IMO no one should've taken SA's article seriously or making investment based on these random and self-serving articles. Another SA article could counter every argument that BN made..
BN's article expresses his own interests rather than a neutral scientific approach analysis to present pros and cons of the situation. stock price and the science of Immuno-oncology are two separate topics. If he valued 1135 is a must for CLDX to differentiate itself from other Immu players, then stock should drop further because CLDX has nothing else that push stock price higher since Celldex announced the closing of its DDD study...
He claims: "this news alone is not reason enough for me to sell my position " , but that is the reason makes CLDX no longer a rare breed of immuno-oncology and orphan. Somehow he expects CLDX stock goes higher because his speculation of Alexion's interests and hopes that CLDX products can all show a distinct clinical benefit,. He seems to suggest that if CLDX management followed his suggestions which pawn off 1135 assets then his investment could get 5X in return.
He over-played his roles in 15% stock loss ties to his prior speculations as: Many investors thought Celldex had a flawless pipeline and CDX-1135's potential beyond DDD appears high.
These independent writers seem to full of themselves don't they... GL.
CY, don't tell Frank that NWBO is breaking out because it is going down to $8.10 now...and keep going down to $9 by tomorrow, and will going down to $10 by Wednesday... you need to use the right terminology to communicate with him... LOLOLOLOLOL